These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 30121331)

  • 1. Cubic lyotropic liquid crystals as drug delivery carriers: Physicochemical and morphological studies.
    Chountoulesi M; Pippa N; Pispas S; Chrysina ED; Forys A; Trzebicka B; Demetzos C
    Int J Pharm; 2018 Oct; 550(1-2):57-70. PubMed ID: 30121331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid crystalline nanoparticles for drug delivery: The role of gradient and block copolymers on the morphology, internal organisation and release profile.
    Chountoulesi M; Perinelli DR; Forys A; Bonacucina G; Trzebicka B; Pispas S; Demetzos C
    Eur J Pharm Biopharm; 2021 Jan; 158():21-34. PubMed ID: 33098976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimuli-Responsive Lyotropic Liquid Crystalline Nanosystems with Incorporated Poly(2-Dimethylamino Ethyl Methacrylate)-b-Poly(Lauryl Methacrylate) Amphiphilic Block Copolymer.
    Chountoulesi M; Pippa N; Chrysostomou V; Pispas S; Chrysina ED; Forys A; Otulakowski L; Trzebicka B; Demetzos C
    Polymers (Basel); 2019 Aug; 11(9):. PubMed ID: 31454966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of stimuli-responsive lyotropic liquid crystalline nanoparticles targeting lysosomes: Physicochemical, morphological and drug release studies.
    Chountoulesi M; Perinelli DR; Forys A; Chrysostomou V; Kaminari A; Bonacucina G; Trzebicka B; Pispas S; Demetzos C
    Int J Pharm; 2023 Jan; 630():122440. PubMed ID: 36436746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phytantriol based smart nano-carriers for drug delivery applications.
    Akbar S; Anwar A; Ayish A; Elliott JM; Squires AM
    Eur J Pharm Sci; 2017 Apr; 101():31-42. PubMed ID: 28137471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic ionizable aminolipids induce a pH dependent inverse hexagonal to bicontinuous cubic lyotropic liquid crystalline phase transition in monoolein nanoparticles.
    Rajesh S; Zhai J; Drummond CJ; Tran N
    J Colloid Interface Sci; 2021 May; 589():85-95. PubMed ID: 33450463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Freeze-dried and re-hydrated liquid crystalline nanoparticles stabilized with disaccharides for drug-delivery of the plectasin derivative AP114 antimicrobial peptide.
    Boge L; Västberg A; Umerska A; Bysell H; Eriksson J; Edwards K; Millqvist-Fureby A; Andersson M
    J Colloid Interface Sci; 2018 Jul; 522():126-135. PubMed ID: 29587194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Influence of Hydrophobic Blocks of PEO-Containing Copolymers on Glyceryl Monooleate Lyotropic Liquid Crystalline Nanoparticles for Drug Delivery.
    Forys A; Chountoulesi M; Mendrek B; Konieczny T; Sentoukas T; Godzierz M; Kordyka A; Demetzos C; Pispas S; Trzebicka B
    Polymers (Basel); 2021 Aug; 13(16):. PubMed ID: 34451146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Lamellar Lyotropic Liquid Crystalline Lipid Nanoparticles for the Next Generation of Nanomedicine.
    Zhai J; Fong C; Tran N; Drummond CJ
    ACS Nano; 2019 Jun; 13(6):6178-6206. PubMed ID: 31082192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Size and phase control of cubic lyotropic liquid crystal nanoparticles.
    Hartnett TE; Ladewig K; O'Connor AJ; Hartley PG; McLean KM
    J Phys Chem B; 2014 Jul; 118(26):7430-9. PubMed ID: 24915497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel steric stabilizers for lyotropic liquid crystalline nanoparticles: PEGylated-phytanyl copolymers.
    Chong JY; Mulet X; Keddie DJ; Waddington L; Mudie ST; Boyd BJ; Drummond CJ
    Langmuir; 2015 Mar; 31(9):2615-29. PubMed ID: 25068381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-assembled multicompartment liquid crystalline lipid carriers for protein, peptide, and nucleic acid drug delivery.
    Angelova A; Angelov B; Mutafchieva R; Lesieur S; Couvreur P
    Acc Chem Res; 2011 Feb; 44(2):147-56. PubMed ID: 21189042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-Based Liquid Crystals As Carriers for Antimicrobial Peptides: Phase Behavior and Antimicrobial Effect.
    Boge L; Bysell H; Ringstad L; Wennman D; Umerska A; Cassisa V; Eriksson J; Joly-Guillou ML; Edwards K; Andersson M
    Langmuir; 2016 May; 32(17):4217-28. PubMed ID: 27033359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simple-by-design approach for production of stabilizer-free cubosomes from phosphatidylglycerol and docosahexaenoic acid monoacylglycerol.
    Kalaycioglu GD; Bor G; Yaghmur A
    J Colloid Interface Sci; 2024 Dec; 675():825-835. PubMed ID: 39002233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lyotropic Liquid Crystalline Nanostructures as Drug Delivery Systems and Vaccine Platforms.
    Chountoulesi M; Pispas S; Tseti IK; Demetzos C
    Pharmaceuticals (Basel); 2022 Mar; 15(4):. PubMed ID: 35455426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lyotropic liquid crystalline phases: Drug delivery and biomedical applications.
    Chavda VP; Dyawanapelly S; Dawre S; Ferreira-Faria I; Bezbaruah R; Rani Gogoi N; Kolimi P; Dave DJ; Paiva-Santos AC; Vora LK
    Int J Pharm; 2023 Nov; 647():123546. PubMed ID: 37884213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of bicontinuous cubic liquid crystalline systems of phytantriol and water using cryo field emission scanning electron microscopy (cryo FESEM).
    Rizwan SB; Dong YD; Boyd BJ; Rades T; Hook S
    Micron; 2007; 38(5):478-85. PubMed ID: 17011783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revisiting β-casein as a stabilizer for lipid liquid crystalline nanostructured particles.
    Zhai J; Waddington L; Wooster TJ; Aguilar MI; Boyd BJ
    Langmuir; 2011 Dec; 27(24):14757-66. PubMed ID: 22026367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of β-casein stabilized lipopeptide lyotropic liquid crystal nanoparticles for delivery of doxorubicin.
    Wang D; Ma B; Wang Z; Zhao Y; Sun Y; Luan Y; Wang J
    Soft Matter; 2019 Nov; 15(44):9011-9017. PubMed ID: 31687734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current potential and challenges in the advances of liquid crystalline nanoparticles as drug delivery systems.
    Madheswaran T; Kandasamy M; Bose RJ; Karuppagounder V
    Drug Discov Today; 2019 Jul; 24(7):1405-1412. PubMed ID: 31102731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.